Company Filing History:
Years Active: 2018
Title: Innovations of Sungsu Lim in Histone Methyltransferase Inhibition
Introduction
Sungsu Lim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that target histone methyltransferases. His work is crucial for advancing therapeutic strategies in various diseases.
Latest Patents
Sungsu Lim holds a patent for "Quinoline derivatives for inhibiting histone methyltransferases and use thereof." This patent describes a quinoline derivative that inhibits the activity of histone methyltransferases, specifically ESET/SETDB1, which is associated with the histone molecule H3K9. The invention also includes pharmaceutically acceptable salts of the compound and outlines its potential applications in medicine.
Career Highlights
Sungsu Lim is affiliated with the Korea Institute of Science and Technology, where he conducts research and development in innovative biochemical solutions. His work has led to advancements in understanding the mechanisms of histone modification and its implications in gene regulation.
Collaborations
Sungsu Lim collaborates with esteemed colleagues, including Hyunah Choo and Sun-Joon Min, to further explore the applications of his research. Their combined expertise enhances the potential impact of their findings in the scientific community.
Conclusion
Sungsu Lim's innovative work in developing quinoline derivatives represents a significant advancement in the field of histone methyltransferase inhibition. His contributions are poised to influence future therapeutic approaches in treating various diseases.